Drug
Bps804
Bps804: highest development phase Phase 2, developed by Ultragenyx Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BPS804 NCT01806610 | Phase 2 | Chronic-kidney Disease Stage 5D on Stable Hemodialysis |
| BPS804 NCT03216486 | Phase 2 | Osteogenesis Imperfecta |
| BPS804 NCT01417091 | Phase 2 | Osteogenesis Imperfecta |
Latest
No recent events.
Follow Bps804 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.